However, seven children with anti-NXP2 autoantibodies developed calcinosis after their first study visit and all of these had anti-NXP2 autoantibodies present in blood samples predating calcinosis development (taken 2 months–4 years after disease onset). Here, MORC3 is linked to calcinosis.